Veterinary Medicines

Benestermycin

Authorised
  • Framycetin sulfate
  • Benethamine penicillin
  • Penethamate hydriodide
Download as PDF

Product identification

Medicine name:
Benestermycin
Active substance:
  • Framycetin sulfate
  • Benethamine penicillin
  • Penethamate hydriodide
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • Benethamine penicillin
    280.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • Penethamate hydriodide
    100.00
    milligram(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        day
      • Milk
        37
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Pharma Herstellung GmbH
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6180634.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."